Share This Link

Heparin has an immediate onset of action when administered via continuous IV infusion. Therapeutic blood levels, typically measured by an activated partial thromboplastin time (aPTT), are achieved quickly, often within hours, not days, of starting the infusion.

While pharmacists are experts in medication, the nurse is responsible for patient education regarding the therapy being administered. Deferring to the pharmacist fails to provide the immediate, necessary clarification of the medication's therapeutic intent required for informed patient care.

Oral anticoagulants, such as warfarin, are also anticoagulants rather than thrombolytics. Like heparin, they work to prevent future coagulation and do not have the pharmacological capacity to actively dissolve or break down a pre-existing venous blood clot.

Atorvastatin is typically well-absorbed and can be taken with or without food. Taking it with food can sometimes reduce minor gastrointestinal discomfort, but it is not a requirement for absorption or the efficacy of the medication.

Clay-colored stools are a sign of hepatotoxicity or biliary obstruction. This is a severe adverse reaction that requires immediate medical evaluation and cessation of the medication, rather than an expected finding during the course of standard statin therapy.

Routine lab tests, specifically liver function tests (LFTs) and occasionally creatine kinase levels, are required for patients on statins. Monitoring LFTs is essential to detect early drug-induced liver injury, which may occur even in asymptomatic patients taking this medication.

Potassium chloride is a mineral supplement used to treat or prevent hypokalemia. It has no pharmacological role in the reversal of heparin-induced anticoagulation and would not stop bleeding caused by an anticoagulant overdose.

Vitamin E is a fat-soluble vitamin. While it has some mild anti-platelet effects at high doses, it does not function as an antidote to heparin and has no role in the emergency management of anticoagulant-induced excessive bleeding.

Vitamin K is the pharmacological antidote for warfarin, a vitamin K antagonist. It functions by promoting the synthesis of clotting factors in the liver and is completely ineffective at neutralizing the anticoagulant effects of intravenous heparin.

Corticosteroids are effective anti-inflammatory agents used to reduce airway inflammation in asthma. However, they have a delayed onset of action, making them inappropriate as the sole or initial treatment for rapid bronchodilation during an acute asthma attack.

Anticholinergics like ipratropium bromide can be used as an adjunct in acute asthma management, especially in severe cases. They are not the first-line initial treatment, which remains a fast-acting bronchodilator to address acute airway obstruction immediately.

Long-acting beta 2 agonists are maintenance medications used for long-term control of asthma. They have a slow onset of action and are not indicated for use during an acute asthma attack, as they do not provide rapid bronchodilation.

The route of administration refers to how the drug enters the body, such as intravenous, oral, or subcutaneous. The error in this scenario is related to the timing of the infusion, not the physical pathway used for delivery.

The wrong drug error occurs when a patient receives a medication different from the one prescribed by the provider. The heparin infusion in this scenario is the correct medication, but it was administered for longer than the prescribed duration.

A wrong dose error occurs when the amount of medication administered is not what was ordered. While the patient received an extra total dose of heparin, the error is fundamentally categorized as a timing issue because it was stopped late.

Tolerance refers to a decreased physiological response to a medication after repeated exposure. The patient's symptoms are acute signs of an immune-mediated hypersensitivity reaction, not a reduction in the therapeutic or side-effect response to the antibiotic medication.

Clostridium difficile is a bacterial infection of the colon often caused by antibiotic therapy due to the disruption of normal intestinal flora. It typically presents with severe diarrhea, not acute systemic allergic symptoms like hives or tongue swelling.

A superinfection is a new infection that develops during treatment for a primary infection, often due to the eradication of protective commensal bacteria. These infections involve the growth of resistant organisms and do not manifest as immediate, systemic anaphylactic reactions.

Asking what a patient takes for pain is a closed-ended question that yields limited information only about pain management. It fails to capture data about other medications, supplements, or health practices that the patient may be utilizing for other conditions.

Asking if a patient knows the side effects of their medications is a closed-ended, leading question that results in a simple yes or no response. It does not provide the nurse with detailed information about the patient's current medication use.

Asking why medications are taken at night assumes the patient takes them at night. This is a restrictive, leading question that fails to elicit a complete, patient-centered history regarding the full range of medications taken throughout the entire day.

There is no standard clinical requirement to restrict fluid intake to 2500 mL per day for patients on antithyroid therapy. Fluid management should be individualized based on the patient's clinical status, not as a general instruction for this drug class.

Increasing sodium and potassium intake is not a standard requirement for patients on antithyroid therapy. Dietary sodium and potassium balance should be maintained within normal limits unless the patient has a specific clinical condition requiring modification of these electrolytes.

Iodized salt is a significant source of dietary iodine. Using it while taking antithyroid medication interferes with the drug's mechanism of action, which is designed to block iodine utilization, thereby reducing the overall effectiveness of the treatment for the patient.